NFE2L2 and neoplasm: Comparison of the TAL and RMC populations from the treated tumour revealed a transcriptional switch from high HOXB9 and TFCP2L1 activity in TAL1 cells, to high MYC, HIF1A, YY1 and NFE2L2 activity in RMC cells (Fig. 2g).